Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 5/2013

01-10-2013 | Editorial

Decision aids for breast cancer chemoprevention

Published in: Breast Cancer Research | Issue 5/2013

Login to get access

Abstract

The article by Korfage and colleagues in this issue of Breast Cancer Research highlights the importance of enabling women to make informed choices about breast cancer chemoprevention. Decision aids have the potential to improve knowledge and decision-making in this context, but they do not guarantee increased uptake of chemoprevention amongst high-risk women if this option is inconsistent with women’s values. Important avenues for further research in this area include evaluating: decision aids with explicit values clarification exercises and with comparison between chemoprevention and nonpharmacological options to reduce breast cancer risk, the influence of mediating factors such as anxiety and risk perception, and the role of clinicians and family members in decision-making.
Literature
1.
Korfage I, Fuhrel-Forbis A, Ubel P, Zikmund-Fisher B, Greene S, McClure J, Smith D, Hensly Alford S, Fagerlin A: Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention. Breast Cancer Res. 2013, 15: R74-10.1186/bcr3468.CrossRefPubMedPubMedCentral
2.
Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, DeCensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG, Wade JL, Lippman SM: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2013, Epub ahead of print
3.
O'Brien MA, Whelan TJ, Villasis-Keever M, Gafni A, Charles C, Roberts R, Schiff S, Cai W: Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol. 2009, 27: 974-985. 10.1200/JCO.2007.16.0101.CrossRefPubMed
4.
Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R: Decision aids for people facing health treatment or screening decisions [review]. Cochrane Database Syst Rev. 2011, 10: CD001431
5.
Ropka ME, Keim J, Philbrick JT: Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol. 2010, 28: 3090-3095. 10.1200/JCO.2009.27.8077.CrossRefPubMedPubMedCentral
6.
Michie S, Dormandy E, Marteau TA: The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002, 48: 87-91. 10.1016/S0738-3991(02)00089-7.CrossRefPubMed
7.
Dillard AJ, Scherer L, Ubel PA, Smith DM, Zikmund-Fisher BJ, McClure JB, Greene S, Stark A, Fagerlin A: Breast cancer anxiety's associations with responses to a chemoprevention decision aid. Soc Sci Med. 2013, 77: 13-19.CrossRefPubMed
8.
Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, Campbell R: Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005, 61: 133-155. 10.1016/j.socscimed.2004.11.063.CrossRefPubMed
9.
Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J, Brundage MD: The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Making. 2012, 32: 616-626. 10.1177/0272989X11434601.CrossRefPubMed
10.
Glynn RW, Kelly JC, Coffey N, Sweeney KJ, Kerin MJ: The effect of breast cancer awareness month on internet search activity: a comparison with awareness campaigns for lung and prostate cancer. BMC Cancer. 2011, 11: 442-10.1186/1471-2407-11-442.CrossRefPubMedPubMedCentral
11.
Metcalfe D, Price C, Powell J: Media coverage and public reaction to a celebrity cancer diagnosis. J Public Health. 2011, 33: 80-85. 10.1093/pubmed/fdq052.CrossRef
12.
13.
Laidsaar-Powell RC, Butow PN, Bu S, Charles C, Gafni A, Lam WWT, Jansen J, McCaffery KJ, Shepherd HL, Tattersall MH, Juraskova I: Physician–patient–companion communication and decision-making: a systematic review of triadic medical consultations. Patient Educ Couns. 2013, 91: 3-13. 10.1016/j.pec.2012.11.007.CrossRefPubMed
14.
Razzaboni E, Toss A, Cortesi L, Marchi I, Sebastiani F, De Matteis E, Federico M: Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center (Italy). Breast J. 2013, 19: 10-21. 10.1111/tbj.12045.CrossRefPubMed
15.
Mulley AG, Sepucha K: Making good decisions about breast cancer chemoprevention. Ann Intern Med. 2002, 137: 52-54. 10.7326/0003-4819-137-1-200207020-00014.CrossRefPubMed
Metadata
Title
Decision aids for breast cancer chemoprevention
Publication date
01-10-2013
Published in
Breast Cancer Research / Issue 5/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3479

Other articles of this Issue 5/2013

Breast Cancer Research 5/2013 Go to the issue

Viewpoint

AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer - culprits for resistance to EGFR inhibitors?

Research article

Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series

Research article

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Research article

Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women

Research article

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment

Research article

The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits